Didier Deltort Joins Vivolta B.V.’s Supervisory Board

Vivolta B.V. has appointed Didier Deltort to its Supervisory Board of Directors.
 
Deltort is currently a senior advisor at several venture capital and private equity firms, with more than 30 years of experience in leading healthcare technology innovations and businesses globally. He brings significant expertise to Vivolta based on a career that includes senior leadership roles at GE Healthcare, Boston Scientific, Zimmer Biomet, and HP Inc.

“Didier’s extensive experience in medical devices and technology will be invaluable to Vivolta’s acceleration, as we continue to co-develop and manufacture electrospun medical products with our Medtech partners. We welcome Didier to the board and look forward to benefiting from his insights and contributions,” Vivolta Board Chairman Rudy Mareel said.
 
During his 14 years at GE Healthcare, Deltort held senior positions in Europe, the Middle East, and the United States, including senior vice president and general manager of Global Monitoring Solutions and managing director of GE Healthcare Finland. He has extensive experience in diagnostic imaging product segments and patient monitoring solutions for acute care settings. As EMEA president at Zimmer Biomet, he supervised the marketing, sales, and distribution of its orthopedics, spine, and dental product ranges as well as robotic surgery solutions. Prior to Zimmer Biomet, he served as senior vice president and general manager of Global Healthcare Solutions and Partnerships at Boston Scientific. Most recently, Deltort was the global president of HP Inc.’s Personalization & 3D Printing division.
 
Deltort earned a master’s degree in biomedical engineering from the Université de Technologie de Compiègne, France.
 
“Having spent many years working on innovative healthcare technologies, I recognize the transformative potential of Vivolta’s unique medical electrospinning solutions, particularly their fully automated MediSpin production platform,” Deltort stated. “This integrated approach could revolutionize numerous textile-based and regenerative applications in the Medtech industry. I am looking forward to collaborating with Vivolta’s Management and Board to achieve significant clinical and commercial milestones.”
 
Vivolta B.V. develops and manufactures electrospinning solutions for the medical industry, providing technologies to enhance the creation of medical devices. Using its proprietary, fully automated MediSpin production platform, Vivolta supports its clients in realizing electrospun medical solutions that guide the body to heal itself. Vivolta’s solutions are applicable to a broad array of high-value therapeutic areas with unmet clinical need, such as cardiovascular implants, soft tissue repair, orthopedic sports medicine, and drug delivery. The company, formerly IME Medical Electrospinning, is a pioneer and global leader in the electrospinning sector, having contributed significantly to the first ASTM (American Society for Testing and Materials) standard for fiber-based medical scaffolds (F3519-21), published in 2021.